Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating https://alvinikia936808.thekatyblog.com/34726383/tirzepatide-a-promising-new-treatment-for-obesity